InsiderClue
← All stocks

Celldex Therapeutics, Inc.

CLDX Net selling
CIK 0000744218 #1725 in the set updated 21 Sep 2026
Bought (120 mo)
$490.90K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$24.30M
$0.00 on a plan · $22.57M straight out of an exercise
Sold at will
$1.73M
4 of 44 sales
Net
−$23.81M
−$1.24M against sales at will

By person

17 insiders · 65 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Marucci Anthony S
PRESIDENT & CEO
$354.33K (2)
$4.52M (1) scheduled
−$4.17M
40,284
0.0513%
$1.17M
+293.1%
Wright Richard M.
Former Officer
—
$3.73M (6) scheduled
−$3.73M
20,833
0.0265%
$606.14K
+9,916%
Martin Samuel Bates
SVP AND CFO
$29.74K (1)
$3.47M (11) scheduled
−$3.44M
32,942
0.0419%
$958.45K
+3,244%
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
$3.01K (1)
$3.33M (4) scheduled
−$3.33M
13,383
0.0170%
$389.38K
+1,123%
Crowley Elizabeth
SR. VP & CPDO
—
$3.22M (7) scheduled
−$3.22M
9,074
0.0116%
$264.01K
+1,759%
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
$5.07K (1)
$2.51M (7) scheduled
−$2.51M
1,860
0.0024%
$54.12K
−14.6%
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
$10.00K (1)
$2.49M (3)
−$2.48M
17,115
0.0218%
$497.96K
—
KELER TIBOR
EXECUTIVE VP & CSO
$24.74K (2)
$622.61K (1) scheduled
−$597.87K
7,357
0.0094%
$214.05K
—
Jimenez Freddy A.
SVP & GENERAL COUNSEL
$19.90K (1)
$409.31K (4) scheduled
−$389.41K
30,796
0.0392%
$896.01K
+1,828%
MARINO JAMES J
Director
$44.12K (2)
—
+$44.12K
2,204
0.0028%
$64.13K
—
McMahon Gerald PhD
Director
—
—
—
180,697
0.2301%
$5.26M
−32.4%
ELLBERGER LARRY
Director
—
—
—
73,500
0.0936%
$2.14M
+15.7%
PENNER HARRY JR
Director
—
—
—
41,916
0.0534%
$1.22M
+31.3%
Shoos Karen L.
Director
—
—
—
41,833
0.0533%
$1.22M
+31.4%
CONRAD HERBERT J
Director
—
—
—
38,500
0.0490%
$1.12M
+35.1%
PEPIN RONALD
SR. VP & CBO
—
—
—
20,097
0.0256%
$584.72K
+2,530%
Brownlie Keith L
Director
—
—
—
10,000
0.0127%
$290.95K
—

Individual transactions

40
Insider
Date
Role
Action
Shares
Price
Amount
Wright Richard M.
13 Nov 2025
Former Officer
Sold after exercise
49,298
$24.00
$1.18M
Martin Samuel Bates
14 Jun 2024
SVP AND CFO
Sold after exercise
17,172
$35.42
$608.31K
Crowley Elizabeth
14 Jun 2024
SR. VP & CPDO
Sold after exercise
30,000
$34.87
$1.05M
Crowley Elizabeth
7 Jun 2024
SR. VP & CPDO
Sold after exercise
15,000
$35.06
$525.87K
Jimenez Freddy A.
3 Jun 2024
SVP & GENERAL COUNSEL
Sold after exercise
8,006
$33.60
$269.00K
Wright Richard M.
3 Jun 2024
SR. VP & CCO
Sold after exercise
19,264
$33.99
$654.69K
Wright Richard M.
3 Jun 2024
SR. VP & CCO
Sold after exercise
27,580
$33.53
$924.66K
Heath-Chiozzi Margo
3 Jun 2024
SVP OF REGULATORY AFFAIRS
Sold after exercise
58,369
$33.65
$1.96M
Crowley Elizabeth
30 May 2024
SR. VP & CPDO
Sold after exercise
38,597
$33.64
$1.30M
Cavanaugh Sarah
30 May 2024
SVP OF CORP AFFAIRS & ADMIN.
Sold after exercise
20,853
$33.73
$703.33K
Martin Samuel Bates
30 May 2024
SVP AND CFO
Sold after exercise
35,000
$34.05
$1.19M
Heath-Chiozzi Margo
30 May 2024
SVP OF REGULATORY AFFAIRS
Sold after exercise
38,719
$34.07
$1.32M
KELER TIBOR
7 Dec 2022
EXECUTIVE VP & CSO
Sold after exercise
16,860
$36.93
$622.61K
Cavanaugh Sarah
18 Aug 2022
SVP OF CORP AFFAIRS & ADMIN.
Sold after exercise
1,355
$36.38
$49.29K
Young Diane C.
17 Aug 2022
SVP, CHIEF MEDICAL OFFICER
Sold after exercise
19,000
$37.30
$708.72K
Cavanaugh Sarah
17 Aug 2022
SVP OF CORP AFFAIRS & ADMIN.
Sold after exercise
31,312
$36.73
$1.15M
Wright Richard M.
15 Aug 2022
SR. VP & CCO
Sold after exercise
15,328
$37.71
$578.05K
Marucci Anthony S
15 Aug 2022
PRESIDENT & CEO
Sold after exercise
120,000
$37.66
$4.52M
Martin Samuel Bates
12 Aug 2022
SVP AND CFO
Sold after exercise
1,221
$34.62
$42.27K
Martin Samuel Bates
12 Aug 2022
SVP AND CFO
Sold after exercise
2,065
$35.38
$73.05K
Martin Samuel Bates
12 Aug 2022
SVP AND CFO
Sold after exercise
14,261
$36.76
$524.30K
Martin Samuel Bates
11 Aug 2022
SVP AND CFO
Sold after exercise
2,453
$37.04
$90.86K
Martin Samuel Bates
23 Dec 2021
SVP and CFO
Sold after exercise
9,500
$42.00
$399.00K
Heath-Chiozzi Margo
8 Dec 2021
SVP of Regulatory Affairs
Sold after exercise
600
$40.00
$24.00K
Crowley Elizabeth
8 Dec 2021
Sr. VP &CPDO
Sold after exercise
4,000
$40.00
$160.00K
Cavanaugh Sarah
8 Dec 2021
SVP of Corp Affairs & Admin.
Sold after exercise
7,323
$40.00
$292.92K
Martin Samuel Bates
15 Nov 2021
SVP and CFO
Sold after exercise
2,048
$42.27
$86.57K
Martin Samuel Bates
15 Nov 2021
SVP and CFO
Sold after exercise
7,452
$43.92
$327.31K
Young Diane C.
12 Nov 2021
SVP, Chief Medical Officer
Sold after exercise
4,600
$42.94
$197.53K
Heath-Chiozzi Margo
1 Nov 2021
SVP of Regulatory Affairs
Sold after exercise
600
$41.71
$25.03K
Crowley Elizabeth
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
1,189
$41.62
$49.48K
Crowley Elizabeth
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
600
$43.11
$25.87K
Crowley Elizabeth
1 Nov 2021
Sr. VP &CPDO
Sold after exercise
2,528
$44.12
$111.53K
Cavanaugh Sarah
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
2,120
$41.62
$88.23K
Cavanaugh Sarah
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
901
$43.06
$38.80K
Cavanaugh Sarah
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold after exercise
4,302
$44.11
$189.77K
Martin Samuel Bates
10 Aug 2021
SVP and CFO
Sold after exercise
682
$45.25
$30.86K
Martin Samuel Bates
10 Aug 2021
SVP and CFO
Sold after exercise
2,056
$45.25
$93.03K
Wright Richard M.
14 Dec 2020
Sr. VP & CCO
Sold after exercise
9,375
$18.61
$174.44K
Wright Richard M.
14 Dec 2020
Sr. VP & CCO
Sold after exercise
11,457
$18.61
$213.17K
Show all 65 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,008,121
History held since 6 Sep 2016